Influence of antidepressant use on glycemic control in patients with diabetes mellitus: an open-label comparative study

被引：0
|
作者：
Derijks, H. J. [1 ,2 ]
Janknegt, R. [2 ]
Heerdink, E. R. [1 ]
De Koning, G. H. P. [1 ,3 ]
Krekels, M. M. [4 ]
Looij, B. J. [4 ]
Egberts, A. C. G. [1 ,5 ]
机构：
[1] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Pharmacotherapy, Utrecht, Netherlands
[2] Orbis Med Ctr, Dept Clin Pharm, Sittard, Netherlands
[3] Assoc Kring Apotheken Netherlands, Den Bosch, Netherlands
[4] Orbis Med Ctr, Dept Internal Med, Sittard, Netherlands
[5] Univ Med Ctr Utrecht, Dept Clin Pharm, Utrecht, Netherlands
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2009年 / 68卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：783 / 784
页数：2
相关论文
共 50 条
  • [1] INFLUENCE OF ANTIDEPRESSANT USE ON GLYCEMIC CONTROL IN PATIENTS WITH DIABETES MELLITUS: AN OPEN-LABEL COMPARATIVE STUDY
    Derijks, H. J.
    Janknegt, R.
    Heerdink, E. R.
    de Koning, G. H.
    Krekels, M. M.
    Looij, B. J.
    Egberts, A. C.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 39 - 39
  • [2] Influence of Antidepressant Use on Glycemic Control in Patients With Diabetes Mellitus An Open-Label Comparative Study
    Derijks, Hieronymus J.
    Janknegt, Robert
    Heerdink, Eibert R.
    De Koning, Fred H. P.
    Krekels, Marielle M.
    Looij, Bert-Jan
    Egberts, Antoine C. G.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2009, 29 (04) : 405 - 408
  • [3] Lipid effects of glyburide/metformin tablets in patients with type 2 diabetes mellitus with poor glycemic control and dyslipidemia in an open-label extension study
    Dailey, GE
    Mohideen, P
    Fiedorek, FT
    CLINICAL THERAPEUTICS, 2002, 24 (09) : 1426 - 1438
  • [4] Metformin improves glycemic variability in adults with type 1 diabetes mellitus: an open-label randomized control trial
    Zhang, Xiuzhen
    Xu, Dan
    Xu, Ping
    Yang, Shufen
    Zhang, Qingmei
    Wu, Yan
    Yuan, Fengyi
    ENDOCRINE CONNECTIONS, 2021, 10 (09) : 1045 - 1054
  • [5] Manidipine for Hypertension not Controlled by Dual Therapy in Patients with Diabetes Mellitus A Non-Comparative, Open-Label Study
    Martell-Claros, Nieves
    Jose de la Cruz, Juan
    CLINICAL DRUG INVESTIGATION, 2011, 31 (06) : 427 - 434
  • [6] Exenatide maintains glycemic control for 2 years in patients with type 2 diabetes: data from an ongoing, open-label study
    Ratner, RE
    Stonehouse, A
    Gao, HY
    Poon, T
    Kim, D
    DIABETOLOGIA, 2005, 48 : A288 - A289
  • [7] Combination of Linagliptin and Metformin Improves Glycemic Control in Type 2 Diabetes: A Randomized Trial with an Open-Label Arm in Patients with Poor Glycemic Control
    Haak, Thomas
    Meinicke, Thomas
    Jones, Russell
    Von Eynatten, Maximilian
    Woerle, Hans J.
    DIABETES, 2011, 60 : A77 - A77
  • [8] Influence of antidepressant use on insulin need in diabetes mellitus patients
    Knol, Mirjam J.
    Derijks, Hieronymus J.
    Geerlings, Mirjam I.
    Heerdink, Eibert R.
    Souverein, Patrick C.
    Grobbee, Diederick E.
    Egberts, Antoine C.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S127 - S127
  • [9] Effects of replacing metformin with pioglitazone on glycemic control in Japanese patients with poorly controlled type 2 diabetes mellitus: A 12-week, open-label, prospective study
    Sakaue, Shinji
    Kamigaki, Mitsunori
    Yoshimura, Haruhiko
    Nishimura, Masaharu
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2008, 69 (04): : 364 - 377
  • [10] Glycemic control and treatment failure with pioglitazone versus glibenclamide in type 2 diabetes mellitus:: a 42-month, open-label, observational, primary label, care study
    Hanefeld, M.
    Pfuetzner, A.
    Forst, T.
    Luebben, G.
    CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (06) : 1211 - 1215
12345